Goldman Sachs Maintains Neutral on Nucor, Raises Price Target to $161
Goldman Sachs analyst Kate McShane maintains Nucor (NYSE:NUE) with a Neutral and raises the price target from $144 to $161.
Uncategorized
UPDATE: ‘CR Engineers Show a Tesla Will Drive With No One in the Driver’s Seat’ -Consumer Reports
https://www.consumerreports.org/autonomous-driving/cr-engineers-show-tesla-will-drive-with-no-one-in-drivers-seat/
Related Posts
Park City Gr Q4 EPS $0.05 Beats $0.04 Estimate, Sales $4.60M Inline
Park City Gr (NASDAQ:PCYG) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 150 percent increase over earnings of $0.02 per share from the same
Pharma Company Organicell Partners With Beauty Health Focusing On Aging & Inflammation Signs
Biopharmaceutical company Organicell Regenerative Medicine Inc (OTC:OCEL) plans to expand into the skincare and haircare industries in partnership with Beauty Health Co (NASDAQ:SKIN). BeautyHealth’s…